Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This trial will study the treatment of sarcoidosis-associated pulmonary arterial hypertension
with inhaled iloprost, a drug approved for primary pulmonary arterial hypertension.